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Background: Pain after laparoscopy is multifactorial and different treatments have been proposed to provide pain 
relief. Multimodal analgesia is now recommended to prevent and treat post-laparoscopy pain. Dexamethasone is 
effective in reducing postoperative pain. The timing of steroid administration seems to be important. We evaluated 
the analgesic efficacy of preoperative intravenous dexamethasone 1 hour before versus during laparoscopic 
cholecystectomy with multimodal analgesia.
Methods: One hundred twenty patients aged 20 to 65 years old were allocated randomly into one of three groups 
(n = 40, in each). The patients in the group N received normal saline 1 hour before induction and after the resection 
of gall bladder. The patients in the group S1 received dexamethasone 8 mg 1 hour before induction and normal saline 
after the resection of gall bladder. The patients in the group S2 received normal saline 1 hour before induction and 
dexamethasone 8 mg after the resection of gall bladder.
Results: VAS scores of group S1 and S2 were lower than that of group N during 48 hours after laparoscopic 
cholecystectomy. There were no significant differences of VAS scores between the group S1 and the group S2. The 
analgesic consumption of group S1 and S2 were significantly lower than that of group N. 
Conclusions: A single dose of dexamethasone (8 mg) intravenously given 1 hour before induction or during 
operation was effective in reducing postoperative pain after laparoscopic cholecystectomy with multimodal 
analgesia. The analgesic efficacy of preoperative intravenous dexamethasone 1 hour before versus during surgery 
was not significantly different. (Korean J Anesthesiol 2011; 61: 315-319)
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Introduction
Laparoscopic cholecystectomy has beneficial effects com-
pared to laparotomy such as a reduced hospitalization period, 
cost, and use of analgesic with improved lung capacity and 
arterial oxygen tension [1,2]. Nevertheless, the degree of pain 
on the first and second day after surgery is no different to 
laparotomy so the use of an effective analgesic is required [1,3]. 
Pain after laparoscopy occurs for various reasons and a 
range of treatments have been suggested for the reduction in 
pain [4,5]. There are reports that local anesthesia saturation [6], 
removal of remaining carbon dioxide [4], administration of anti-
inflammatory analgesic before surgery [7], and dexamethasone 
[8] are effective in postoperative pain management. Recently 
multimodal analgesia methods, where a combination of 
the above methods is used, are recommended for their 
effectiveness [9].
It has been known that intravenous dexamethasone is 
more effective for the prevention of nausea and vomiting after 
surgery when administered after surgery rather than before 
[10]. However, the timing of intravenous dexamethasone 
injection for the purpose of pain relief is not clear yet [8,11,12]. 
The aim of this study was to investigate whether the timing 
of the administration of steroids affects postoperative pain 
management in patients undergoing multimodal analgesia after 
laparoscopic cholecystectomy.
Materials and Methods
This study was approved by the Ethics Committee and the 
research method was explained to the patients to obtain their 
written consent. One hundred and twenty patients who were 
grade 1 and 2 based on the ASA body classification scheduled 
for laparoscopic cholecystectomy under general anesthesia 
were included as subjects in this study. Patients with allergies 
or restrictions to NSAIDs, patients who had been continuously 
taking NSAIDs, patients had been administered narcotic 
analgesics before surgery, patients with a BMI over 30, diabetic 
patients, patients who switched to laparotomy during surgery, 
and patients who were taking medication for chronic pain were 
excluded from the study.
Subjects were randomly assigned to a control group (group 
N), to a group who received 8 mg dexamethasone 1-2 hours 
before surgery (group S1), and to a group who received 8 mg 
dexamethasone during surgery (group S2). There were no signi-
ficant differences in sex ratio, age, weight, height, duration of 
surgery, and duration of anesthesia between the groups (Table 1). 
In a visit before surgery, the notion of VAS (visual analog 
scale) was thoroughly explained (0 = no pain, 10 = unimaginably 
severe pain). An hour before surgery, group S1 received 8 mg 
of dexamethasone while group N and group S2 received the 
same amount of normal saline (1.6 ml) as the preanesthetic 
administration by a nurse unaware of the research. 
When the patients arrived in the operating room, an ECG, 
pulse oxygen monitor, and non-invasive automatic BPM 
were attached and the patients’ states were monitored during 
surgery. 2 mg/kg of propofol was IV injected for the loss of 
consciousness, intubation was done after IV injection of 0.6 mg/
kg rocuronium bromide, and anesthesia was maintained with 
1.5 L/min of O2, 1.5 L/min of N2O, and 1.5-2.5% of sevoflurane. 
Tidal volume and breathing rate were controlled to maintain a 
35-40 mmHg end tidal CO2. All patients were IV injected with 
30mg of ketorolac after intubation. 
One surgeon fully experienced in laparoscopic cholecystec-
tomy did all the surgeries the same. The operating table was 
adjusted for the patient to be in the 15-20
o trendelenburg 
position and CO2 gas was injected into the abdominal cavity 
through a Veress needle inserted into the incision below the 
belly button. After creating a state of pneumoperitoneum, the 
operation was done with the patient in an inverse trendelenburg 
position. To minimize hemodynamic effects, the abdominal 
pressure was maintained at 12 mmHg. The incision area was 
locally infiltrated with 3 ml of 1% lidocaine before insertion 
of the Veress needle or Trocar. After confirming that the gall 
bladder was removed with the laparoscope, group S2 was IV 
injected with 8 mg of dexamethasone while group N and group 
Table 1. Demographic Data
Group N (n = 40) Group S1 (n = 40) Group S2 (n = 40)
ASA status (1/2)
Age (yr)
Sex (M/F)
Height (cm)
Weight (kg)
Duration of surgery (min)
Duration of anesthesia (min)
27/13
  47.5 ± 13.5
25/15
166.7 ± 7.8
  66.8 ± 11.3
  33.8 ± 12.4
  56.4 ± 12.4
25/15
48.6 ± 10.2
23/17
163.2 ± 7.8
65.5 ± 10.2
 30.8 ± 8.6
53.9 ± 8.2
26/14
  49.5 ± 10.2
22/18
162.1 ± 8.4
  63.3 ± 10.9
 31.4 ± 9.9
  54.6 ± 10.3
Values are mean ± SD or number of patients. Group N: Normal saline, Group S1: dexamethasone 8 mg i.v. 1 hr before operation, Group S2: 
dexamethasone 8 mg i.v. after gallbladder resection. ASA: American Society of Anesthesiologists, There are no significant differences among the 
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S1 received the same volume as normal saline (1.6 ml). After 
the surgery was completed, the operating surgeon pressed the 
patient’s abdomen by hand to remove the remaining CO2 within 
the abdominal cavity before stitching up the skin incision. After 
the surgery, muscle relaxation was reversed with glycopyrrolate 
and pyridostigmine, and the patient was awakened. 
An anesthesiologist with no knowledge of the patients’ 
groups measured the degree of pain with VAS at 1, 3, 6, 24, and 
48 hours after surgery based on the time the patient was moved 
to the recovery room. When the patient requested analgesic 
due to pain or the VAS was higher than 4, 30 mg of ketorolac 
was IV injected first, and 30 minutes later if the VAS was still 
higher than 4, 50 mg of tramadol was IV injected. When the 
pain continued, 50 mg of meperidine was IM injected, and the 
amount of analgesic administered during the 48 hours after 
surgery was recorded. Patients were observed for complaints 
of nausea and vomiting for 24 hours after surgery, and when 
necessary, 4 mg of ondansetron was IV injected. 
Referring to Mentes et al. [13], the study was done on 40 
patients in each group. All results were expressed as the mean 
± standard deviation. A one-way ANOVA was done for com-
parison of VAS between the control group (group N) and 
steroid group (groups S1 and S2) according to time, and a 
student t-test done for the comparison within the steroid group. 
A repeated measures ANOVA was done for the comparison 
analysis to test the treatment effect of steroids or the timing 
of the administration of steroids regarding the repeated 
measurements of VAS. A one-way ANOVA was done to compare 
the amount of ketorolac and tramadol administered to the 
control group and the 2 steroid groups. SAS Enterprize guide 4.1 
(SAS Institute, Cary, NC) was used as a statistics program and 
the results were considered statistically significant when value 
the P was less than 0.05.
Results
The VAS of groups S1 and S2 significantly decreased during 1, 
3, 6, 24, and 48 hours postoperatively compared to group N (Fig. 
1). However, there was no significant difference in VAS between 
group S1 and S2 (Fig. 1). The repeated measures ANOVA 
analysis results regarding the repeat measurements of VAS 
also confirmed that steroid administration caused a significant 
decrease in VAS, and the difference according to the timing of 
the administration of the steroid was not observed (Fig. 1). 
The amount of ketorolac and tramadol IV injected during 
the 48 hours postoperatively was significantly reduced in group 
S1 and group S2 compared to group N (Table 2). No groups 
required intramuscular injection of 50 mg of meperidine for 
pain reduction after surgery. There were no patients in group 
S1 who complained of nausea or vomiting during the first 24 
hours postoperatively, and 1 patient each in group N and group 
S2 complained of vomiting, but IV injection of ondansetron was 
not necessary. 
Intravenous dexamethasone was very effective in the 
postoperative pain management of patients undergoing 
multimodal analgesic after laparoscopic cholecystectomy. 
There were no differences in the degree of pain or usage of 
analgesic between administering dexamethasone 1 hour before 
surgery or during surgery.
Discussion
After laparoscopic cholecystectomy, patients complain 
of pain from the incision of the skin, of visceral pain, and of 
shoulder pain from diaphragm stimulation [14]. Since pain is 
caused by various reasons, a range of treatment methods has 
been introduced for the reduction of pain [4,5]. 
In the case of local anesthetic infiltration, there are various 
results according to research, and while local anesthetic infil-
tration in the incision area is the recommended pain manage-
Fig. 1. Changes in postoperative pain among groups during perio-
perative periods. Patient’s assessment of pain is described as VAS 
scores. Patients who received dexamethasone suffered significantly 
less pain during 48 hours after laparoscopic cholecystectomy. Group 
N: Normal saline, Group S1: steroid 8mg i.v. 1 hr before operation, 
Group S2: steroid 8 mg i.v. after gallbladder resection. *P < 0.001 
one-way ANOVA among groups.
Table 2. Analgesic Consumptions during 48 Hours after Laparoscopic 
Cholecystectomy
Group N  
(n = 40)
Group S1  
(n = 40)
Group S2  
(n = 40)
Ketorolac (mg)
Tramadol (mg)
51.0 ± 33.1
16.6 ± 55
30.0 ± 29.1*
6.5 ± 17.5*
25.2 ± 29.1*
5.5 ± 19.5*
Values are mean ± SD or number of patients. Group N: Normal 
saline, Group S1: steroid 8 mg i.v. 1 hr before operation, Group S2: 
steroid 8 mg i.v. after gallbladder resection. *P < 0.001 one-way 
ANOVA among groups.318 www.ekja.org
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ment method in laparoscopic cholecystectomy, infusion of 
local anesthesia into the abdominal cavity is reported to be 
more effective in obstetrics and gynecology laparo  scopy [6,9,15]. 
Non-steroidal anti-inflammatory drugs are recommended to be 
used before surgery, before anesthesia, or even during surgery, 
and for 3-4 days after surgery [9]. There are also reports that 
the remaining CO2 in the abdominal cavity is related to the 
postoperative pain so thorough removal of the remaining CO2 is 
effective [4]. There are reports that dexamethasone is effective in 
pain reduction after laparoscopic cholecystectomy [8]. Recently 
however, a multimodal analgesic method, which combines and 
utilizes the above methods is recommended [9]. 
The mechanisms of the pain relief for the effects of dexa-
methasone are not clear yet, but the decrease in cyclooxygenase 
and lipoxygenase products by suppressing phospholipases in 
the periphery plays a major role [16,17]. Additionally, reduced 
bradykinin, which reinforces pain in the inflamed tissue and 
operated area, and the concentration of nerve proteins secreted 
from the periphery nerve system are involved in the pain relief 
effect [18,19]. In our study, when compared to the control 
group, the use of dexamethasone showed a significant decrease 
in VAS at 1, 3, 6, 24, and 48 hours postoperatively and a decrease 
in the use of analgesics. Bisgaard et al. [8] also reported similar 
results but were different to our study in that the VAS was not 
different to the control group at 24 hours postoperatively. The 
reason for this difference may be partially that Bisgaard et al. 
[8] prescribed NSAIDs at regular intervals even without pain 
after surgery, whereas in our study, the pain of the patients was 
assessed to prescribe NSAIDs. 
Considering the fact that 1-2 hours is needed for the onset 
of the medication, to reduce the inflammation response after 
surgery, the timing of the administration of the steroid before 
surgery is important [16]. Bisgaard et al. [8] reported that when 
8 mg of dexamethasone was IV injected 90 minutes before 
laparoscopic cholecystectomy, the postoperative pain and 
required amount of opioids were reduced approximately 50% 
compared to the placebo group. Elhakim et al. [11] reported 
that there was no pain relief effect when dexamethasone was 
IV injected directly before incision of the skin. However, in our 
study, there were no differences in the degree of pain and the 
required amount of analgesics when dexamethasone was IV 
injected during surgery compared to when it was administered 
1 hour preoperatively. The reason for this difference between 
the 2 studies is thought to be from the differences in multimodal 
analgesic methods. Elhakim et al. [11] used infusion of local 
anesthesia into the abdominal cavity in combination, but since 
the pain relief effect of this method is not clear in laparoscopic 
cholecystectomy, its use is not generally recommended [9]. Our 
study used IV injection of NSAIDs when inducing anesthesia 
in combination, which is a recommended pain management 
method although the suitable dosages are in inconclusive [9]. In 
addition, the different purposes of the research, the differences 
in surgery time due to the expertise of the operating surgeon, 
and subjective characteristics of the patients responding to 
the pain could all be involved with the differences in results 
between the 2 studies, and thus, further research regarding this 
may be necessary.
Postoperatively or during chemotherapy, dexamethasone is 
used to reduce nausea and vomiting. Although the mechanism 
is not clear, it is thought to be due to the effect on the gluco-
corticoid receptors in the area of postrema and nucleus tractus 
solitaries [20-22]. Bisgaard et al. [8] reported that nausea or 
vomiting in patients who complained of them was significantly 
reduced when 8 mg of dexamethasone was IV injected before 
surgery. According to Kim et al. [23], the effect of intravenous 
steroid injection on nausea and vomiting within 24 hours 
of surgery were different in relationship to age and was not 
effective for elderly patients. However, in our study, only 1 
patient in each group complained of nausea or vomiting. The 
reason for this relatively low occurrence of nausea and vomiting 
could be unrelated to the IV injection of dexamethasone. 
Whereas Bisgaard et al. [8] used opioids to induce anesthesia 
and administered narcotic analgesic when necessary, our study 
limited the use of opioids to when pain that did not respond 
to NSAIDs occurred. Also the fact that the surgery time was 
relatively shorter than other studies may have contributed to 
these differences.
When steroids are used, complications such as delays in 
recovery, post-operative inflammation, glucose tolerance, and 
ulcers in the gastric mucous membrane can occur. Sauerland 
et al. [24] reported in their meta-analysis that there was no 
significant increase in complications when 15-30 mg/kg 
of methylprednisolone was used in one dose, and this is 50 
times the amount of the 8 mg of dexamethasone. In a meta-
analysis regarding postoperative nausea and vomiting, one IV 
injection of dexamethasone did not increase the occurrence of 
inflammation or other complications [22]. In addition, in our 
study, there were no observations of complications related to 
dexamethasone.
Through this study, it could be concluded that intravenous 
injection of 8 mg of dexamethasone can be helpful in the pain 
management of patients undergoing the multimodal analgesic 
method after laparoscopic cholecystectomy, and that the timing 
of the administration of the steroid did not affect postoperative 
pain management. 
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